Moses vs. Thulium Laser Study

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

July 16, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

May 2, 2023

Conditions
Urinary Tract Stone
Interventions
DEVICE

Holmium laser with Moses lasers

The holmium laser with Moses is FDA approved. It emits two separate laser pulses with a short time interval between them. The first pulse divides the water between the laser fiber tip and the stone and the second pulse hits the stone unobstructed. The goal is to increase stone ablative volume and decrease retropulsion of the stone.

DEVICE

Holmium laser with thulium lasers

The holmium laser with thulium laser is FDA approved. It has a different wavelength then the holmium laser with Moses and thus has slightly different energy properties. It has also been shown to increase ablative volume and decrease retropulsion without any safety concerns

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT04963062 - Moses vs. Thulium Laser Study | Biotech Hunter | Biotech Hunter